209515	1001	T1	III_A		88	7	2	1.3	Patchy Enhancement: Mass sparsely populated with enhancement					ADRIAMYCIN|CYTOXAN|TAXOTERE	0
209521	1001	T2	II_B	Stable Disease	78	7	2	1.3	Patchy Enhancement: Mass sparsely populated with enhancement					ADRIAMYCIN|CYTOXAN|TAXOTERE	-11.36
209534	1002	T1	II_B		29	8	8	1.3	Tissue displacing mass with irregular borders and nodular patterns	Grade III (high)	Necrosis	2	2	ADRIAMYCIN|CYTOXAN|TAXOTERE	0
215147	1002	T4	II_B	Stable Disease	16	8	8	1.3	Tissue displacing mass with irregular borders and nodular patterns	Grade III (high)	Necrosis	2	2	ADRIAMYCIN|CYTOXAN|TAXOTERE	-44.83
215151	1003	T4		Stable Disease	46	8	8	2	Tissue displacing mass with irregular borders and nodular patterns	Grade III (high)	Lobular carcinoma	4	4	AMMNM|CMM|RUME	-8
209389	1004	T1	III_A		91	0	0	2	Diffuse infiltration into tissue	Grade III (high)	Necrosis	5	1.5	ADRIAMYCIN|CYTOXAN|TAXOTERE	0
209500	1004	T2	III_A	Progressive Disease	68	0	0	2	Diffuse infiltration into tissue	Grade III (high)	Necrosis	5	1.5	ADRIAMYCIN|CYTOXAN|TAXOTERE	-25.27
209633	1005	T1	III_A		98			0	Septal spreading	Grade III (high)	Necrosis	2.7	2.7	ADRIAMYCIN|CYTOXAN|TAXOTERE	0
212394	1005	T4		PR	42			0	Septal spreading	Grade III (high)	Necrosis	2.7	2.7	ADRIAMYCIN|CYTOXAN|TAXOTERE	-57.14
210832	1009	T1	II_B		75	0	0	2	Tissue displacing mass with irregular borders and nodular patterns	Grade III (high)	Lobular carcinoma		1.3	ADRIAMYCIN|CYTOXAN|TAXOTERE	0
210841	1009	T2		PR	66	0	0	2	Tissue displacing mass with irregular borders and nodular patterns	Grade III (high)	Lobular carcinoma		1.3	ADRIAMYCIN|CYTOXAN|TAXOTERE	-12
211754	1011	T1	II_B		68	0	0	1	Tissue displacing mass with irregular borders and nodular patterns					ADRIAMYCIN|CYTOXAN|TAXOL	0
211739	1012	T1	III_B		78	8	7	1	Diffuse infiltration into tissue	Indeterminate	Ductal carcinoma	6		ADRIAMYCIN|CYTOXAN|TAXOTERE	0
211746	1012	T2		PR	84	8	7	1	Diffuse infiltration into tissue	Indeterminate	Ductal carcinoma	6		ADRIAMYCIN|CYTOXAN|TAXOTERE	7.69
210891	1016	T1	III_A		73	6	6	0	Tissue displacing mass with irregular borders and nodular patterns	Grade II (intermediate)	Lobular carcinoma	1.5	1.5	ADRIAMYCIN|CYTOXAN|TAXOTERE	0
210965	1016	T2		Stable Disease	60	6	6	0	Tissue displacing mass with irregular borders and nodular patterns	Grade II (intermediate)	Lobular carcinoma	1.5	1.5	ADRIAMYCIN|CYTOXAN|TAXOTERE	-17.81
211158	1019	T1	III_B		115	0	0	0	Single predominant mass with a defined circumference	Grade III (high)	Lobular carcinoma	7.5	7.5	ADRIAMYCIN|CYTOXAN|TZSOTERE	0
211230	1019	T2		PR	68	0	0	0	Single predominant mass with a defined circumference	Grade III (high)	Lobular carcinoma	7.5	7.5	ADRIAMYCIN|CYTOXAN|TZSOTERE	-40.87
211643	1021	T1	III_B		63	6	3	7.5	Diffuse infiltration into tissue	Grade III (high)	Lobular carcinoma	2.4	0.8	ADRIAMYCIN|CYTOXA|CYTOXAN|TAXOTERE	0
214441	1022	T1	III_A		98	8	0	0	Septal spreading	Grade II (intermediate)	Ductal carcinoma	0	0	ADRIAMYCIN|CYCLOPHOSPHAMID|TAXOL	0
214453	1022	T2		Stable Disease		8	0	0	Septal spreading	Grade II (intermediate)	Ductal carcinoma	0	0		
212114	1024	T1	III_A		76	7	0	1	Diffuse infiltration into tissue					CYCLOPHOSPHAMID|DOXORUBICIN|PACLITAXEL	0
211629	1026	T1	II_B		32			18.7	Single predominant mass with a defined circumference					ADRIAMYCIN|CYTOXAN|TAXOTERE	0
214699	1027	T1	II_A		40	2	0	2	Single predominant mass with a defined circumference					ADRIAMYCIN|CYTOXAN	0
212312	1028	T1		Stable Disease	60	0	0	1	Tissue displacing mass with irregular borders and nodular patterns		Ductal carcinoma	0.4	0	ADRIAMYCIN|CYTOXAN|PACLITAXEL|VANCOMYCIN	0
212619	1031	T1	III_A	Stable Disease	43				Tissue displacing mass with irregular borders and nodular patterns	Grade II (intermediate)	Ductal carcinoma		3	ADRIAMYCIN|CYTOXAN|TAXOL	0
212695	1032	T1	II_B		60	8	8	0	Diffuse infiltration into tissue	Grade II (intermediate)	Lobular carcinoma	1.6	1.6		0
213088	1034	T1	III_C		88	0	0	0	Patchy Enhancement: Mass sparsely populated with enhancement	Indeterminate	Ductal carcinoma		0.2	ADRIAMYCIN|CYTOXAN|TAXOL	0
213158	1034	T2	III_C	PR	82	0	0	0	Patchy Enhancement: Mass sparsely populated with enhancement	Indeterminate	Ductal carcinoma		0.2	ADRIAMYCIN|CYTOXAN|TAXOL	-6.82
213782	1035	T1	III_C		100	5	4	3.3	Patchy Enhancement: Mass sparsely populated with enhancement					CYCLOPHOSPHAMID|DOXORUBICIN|PACLITAXEL	0
214064	1035	T2		Stable Disease	90	5	4	3.3	Patchy Enhancement: Mass sparsely populated with enhancement					CYCLOPHOSPHAMID|DOXORUBICIN|PACLITAXEL	-10
214474	1037	T1	III_A		92	0	0	2	Single predominant mass with a defined circumference	Grade III (high)	Ductal carcinoma	0.4		ADRIAMYCIN|CYTOXAN|TAXOL|U	0
214493	1037	T2		Stable Disease		0	0	2	Single predominant mass with a defined circumference	Grade III (high)	Ductal carcinoma	0.4			
214462	1038	T1	III_A		36	0	0	0	Single predominant mass with a defined circumference					ADRIAMYCIN|CYTOXAN|TAXOL	0
214485	1038	T2		Stable Disease		0	0	0	Single predominant mass with a defined circumference						
214987	1039	T2	II_A	Stable Disease	20	0	0	3	Patchy Enhancement: Mass sparsely populated with enhancement					CYCLOPHOSPHAMID|DOXORUBICIN|PACLITAXEL	0
217144	1041	T1	III_C		90			3	Tissue displacing mass with irregular borders and nodular patterns	Grade III (high)	Ductal carcinoma	5.2	5.2	ADRIAMYCIN|CYTOXAN|TAXOTERE	0
217155	1041	T2	III_C	Stable Disease	86			3	Tissue displacing mass with irregular borders and nodular patterns	Grade III (high)	Ductal carcinoma	5.2	5.2	ADRIAMYCIN|CYTOXAN|TAXOTERE	-4.44
215309	1042	T1	II_A		93	7	3	0	Diffuse infiltration into tissue	Indeterminate	Ductal carcinoma	0	0.2	ADRIAMYCIN|CYTOXAN|TAXOTERE	0
215397	1042	T2		Progressive Disease	19	7	3	0	Diffuse infiltration into tissue	Indeterminate	Ductal carcinoma	0	0.2	ADRIAMYCIN|CYTOXAN|TAXOTERE	-79.57
215630	1043	T1	III_B		138	0	4		Patchy Enhancement: Mass sparsely populated with enhancement	Grade III (high)	Lobular carcinoma		0.8	ADRIAMYCIN|CYTOXAN|TAXOTERE	0
215655	1043	T2		Stable Disease	146	0	4		Patchy Enhancement: Mass sparsely populated with enhancement	Grade III (high)	Lobular carcinoma		0.8	ADRIAMYCIN|CYTOXAN|TAXOTERE	5.8
216826	1044	T1			154	0	0	0	Diffuse infiltration into tissue					ADRIAMYCIN|CYTOXAN	0
216719	1045	T1			120				Patchy Enhancement: Mass sparsely populated with enhancement					CYCLOPHOSPHAMID|DOXORUBICIN|PACLITAXEL	0
216803	1045	T2	II_B		42				Patchy Enhancement: Mass sparsely populated with enhancement					CYCLOPHOSPHAMID|DOXORUBICIN|PACLITAXEL	-65
217568	1046	T1	II_A		44	6	8	0	Patchy Enhancement: Mass sparsely populated with enhancement	Grade I (low)	Ductal carcinoma	2.3		CYCLOPHOSPHAMID|DOXORUBICIN	0
217408	1049	T1			41	0	0	0	Single predominant mass with a defined circumference	Grade III (high)	Ductal carcinoma	2		ADRIAMYCIN|CYTOXAN|TAXOL|~	0
217594	1049	T2	III_B		34	0	0	0	Single predominant mass with a defined circumference	Grade III (high)	Ductal carcinoma	2		ADRIAMYCIN|CYTOXAN|TAXOL|~	-17.07
217419	1050	T1			127	0	0	0	Diffuse infiltration into tissue					ADRIAMYCIN|CYTOXAN|TAXOL	0
218564	1055	T1	II_A		50	8	8	0	Tissue displacing mass with irregular borders and nodular patterns	Grade II (intermediate)	Lobular carcinoma	3	3	CYCLOPHOSPHAMID|DOXORUBICIN|PACLITAXEL	0
227672	1056	T4		CR	92	0	0	3	Patchy Enhancement: Mass sparsely populated with enhancement					ADRIAMYCIN|CYTOXAN|TAXOTERE	-14.81
218367	1057	T1	III_B		105	0	0	0	Septal spreading	Indeterminate	Ductal carcinoma	0	0.1	ADRIAMYCIN|CYOTAXAN|TAXOL	0
218521	1058	T1			38	0	0	0	Tissue displacing mass with irregular borders and nodular patterns					ADRIAMYCIN|CYTOXAN|TAXOL	0
227878	1061	T4		PR	20	2	0	2	Patchy Enhancement: Mass sparsely populated with enhancement	Grade III (high)	Ductal carcinoma	1.6	1.5	ADRIAMYCIN|CYTOXAN|TAXOTERE	-66.67
219402	1062	T2	III_A	Stable Disease	85	3	3	1	Diffuse infiltration into tissue					ADRIAMYCIN|CYTOXAN|DAILY XELODA|TAXOTERE|XELODA	10.39
227882	1069	T4		CR	24			0	Diffuse infiltration into tissue					ADRIAMYCIN|CYTOXAN|TAXOL|TAXOTERE	-22.58
221380	1075	T1	III_A		54	0	0	0	Single predominant mass with a defined circumference					ADRIAMYCIN|CYTOXAN|TAXOTERE	0
221399	1077	T1	II_B		51	8	6	3	Tissue displacing mass with irregular borders and nodular patterns					ADRIAMYCIN|CYTOXAN|TAXOTERE	0
221407	1077	T2		CR	39	8	6	3	Tissue displacing mass with irregular borders and nodular patterns					ADRIAMYCIN|CYTOXAN|TAXOTERE	-23.53
221853	1082	T1	III_A		87	7	5	3	Diffuse infiltration into tissue	Grade III (high)	Ductal carcinoma	2.5	0.4	ADRIA|CYTOXAN|TAXOL	0
222598	1084	T1			111	8	0	2.1	Single predominant mass with a defined circumference	Grade III (high)	Ductal carcinoma	6		CYCLOPHOPHAMIDE|DOXORUBICIN|PACLITAXEL|PACLITAXOL	0
225737	1095	T1	III_B		76	8	8	0	Single predominant mass with a defined circumference	Grade II (intermediate)	Mixed Ductal/Lobular carcinoma	3	3	CYCLOPHOSPHAMID|EPIRUBICIN|PACLITAXEL	0
226791	1100	T1													
225635	1103	T1	III_B												
228257	1104	T1	II_B												
228268	1104	T2		PR											
226662	1114	T1	III_B												
226676	1114	T2		Stable Disease											
227545	1127	T2													